Dsm-Firmenich Listed on SIX Swiss Exchange – IPO 2026

Why It Matters

The Swiss listing gives DSM-Firmenich greater access to Swiss and international capital, raises the company’s profile among institutional investors, and strengthens its strategic positioning in key consumer-health and beauty markets. That increased market visibility could accelerate M&A, R&D investment and global expansion plans.

Summary

DSM-Firmenich began trading on the SIX Swiss Exchange following its 2026 IPO, completing a dual listing that combines the legacy businesses of DSM and Firmenich into a global leader in nutrition, beauty and health. Company executives highlighted the merger’s blend of innovation, science and sustainability and noted both firms’ centennial histories as a foundation for growth. Management said investor demand for a Swiss listing prompted the move, which they expect will deepen ties to the Swiss financial market and local investor base. The stock opened in trading at 62.80 CHF.

Original Description

On May 21, 2026, dsm-firmenich AG (“dsm-firmenich”), a global manufacturer of nutrients, flavors and fragrances for the nutrition, health and beauty industry, commenced trading under the ticker symbol DSFIR. Based on an opening price of CHF 62.80 per share, the company’s market capitalization stood at approximately CHF 15.9 billion.

Going Public with the Swiss Stock Exchange: https://six.swiss/4f6JbAN

Get in Touch with us: https://six.swiss/4ae1GzM